Health tech start-up Visit Health is looking to raise around USD 10 million in a Series-A funding to finance its expansion, including increasing number of its empanelled doctors, hospitals, pharmacies and pathological labs, according to a top company official.
The company, an artificial intelligence-based health tech app platform offering preventive and curative, primary healthcare solutions, has already raised a total funding of USD 1.4 million and is backed by investors, including MapmyIndia, Snapdeal co-founders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna.